Abeona Therapeutics Inc.

ABEO

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0000318306

SEC filings (opens in a new tab)

In the last 90 days, Abeona Therapeutics Inc. insiders filed 0 open-market purchases and 10 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $243.3M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Abeona Therapeutics Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026 All holders in Q1 2026

13F holders of ABEO: Q1 2026 compared with Q2 2026
Measure	Q1 2026	Of which not filed for Q2 2026	Q2 2026	Change
Holders	108	1	126	+19
Shares	39.5M	75	39.4M	−141.7K (−0.4%)
Value	$177.1M	$336	$243.3M	+$66.2M (+37.4%)

1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (31)

Institutions that held Abeona Therapeutics Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to ABEO in Q2 2026
Institution	Shares	Value	% of portfolio
Resources Investment Advisors, LLC.	1,653,024	$10.2M	0.09%
Rubric Capital Management LP	608,771	$3.76M	0.03%
Tudor Investment Corp Et Al	360,800	$2.23M	0.01%
Gem Investment Advisors, LLC	99,084	$612.3K	0.38%
CI Private Wealth, LLC	89,908	$555.6K	0.00%
Two Sigma Investments, LP	80,737	$499.0K	0.00%
Y-Intercept (Hong Kong) Ltd	72,373	$447.3K	0.01%
Winton Group Ltd	41,400	$255.9K	0.01%
Main Street Research LLC	38,514	$238.0K	0.01%
Jump Financial, LLC	38,400	$237.3K	0.00%
Jain Global LLC	28,885	$178.5K	0.00%
Wealth Effects LLC	27,250	$168.4K	0.05%
Persistent Asset Partners Ltd	25,745	$159.1K	0.05%
Quantbot Technologies LP	25,349	$156.7K	0.01%
Atom Investors LP	24,870	$153.7K	0.01%
Creative Planning	20,503	$126.7K	0.00%
Natixis	19,631	$116.3K	0.00%
StoneX Group Inc.	17,295	$106.0K	0.00%
SG Americas Securities, LLC	13,015	$80.0K	0.00%
Aries Wealth Management	12,500	$77.3K	0.02%
Ethic Inc.	11,344	$70.1K	0.00%
Two Sigma Securities, LLC	10,177	$62.9K	0.01%
Nisa Investment Advisors, LLC	4,571	$28.2K	0.00%
SRS Capital Advisors, Inc.	3,695	$22.8K	0.00%
Allied Private Wealth LLC	900	$6.12K	0.00%
Global Retirement Partners, LLC	442	$2.73K	0.00%
Fifth Third Bancorp	288	$1.78K	0.00%
Quarry LP	269	$1.66K	0.00%
Fortitude Family Office, LLC	48	$297	0.00%
SJS Investment Consulting Inc.	20	$124	0.00%
Hughes Financial Services, LLC	1	$6	0.00%

Sold out (12)

Institutions that held Abeona Therapeutics Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of ABEO in Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
683 Capital Management, LLC	770,000	$3.45M
Balyasny Asset Management LLC	589,847	$2.64M
Tang Capital Management LLC	400,000	$1.79M
Renaissance Technologies LLC	161,082	$721.6K
XTX Topco Ltd	69,120	$309.7K
Bridgeway Capital Management, LLC	50,000	$224.0K
Los Angeles Capital Management LLC	33,561	$150.4K
Simplex Trading, LLC	31,096	$139.3K
Brevan Howard Capital Management LP	29,263	$131.1K
Cetera Investment Advisers	15,845	$71.0K
Envestnet Asset Management Inc	13,291	$59.5K
Caption Management, LLC	4,874	$21.8K

Not filed for Q2 2026 yet (1)

Institutions that held Abeona Therapeutics Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ABEO in Q1 2026 that haven't filed for Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
CWM, LLC	75	$336